Form 8-K - Current report:
SEC Accession No. 0001213900-25-002071
Filing Date
2025-01-08
Accepted
2025-01-08 16:05:09
Documents
17
Period of Report
2025-01-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0227130-8k_citius.htm   iXBRL 8-K 33980
2 FORM OF INVESTOR WARRANT ISSUED ON JANUARY 8, 2025 ea022713001ex4-1_citius.htm EX-4.1 109482
3 OPINION OF WYRICK ROBBINS YATES & PONTON LLP ea022713001ex5-1_citius.htm EX-5.1 10033
4 FORM OF SECURITIES PURCHASE AGREEMENT, DATED AS OF JANUARY 7, 2025, BY AND AMONG ea022713001ex10-1_citius.htm EX-10.1 210155
5 PRESS RELEASE, DATED JANUARY 8, 2025 ea022713001ex99-1_citius.htm EX-99.1 11620
  Complete submission text file 0001213900-25-002071.txt   640720

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ctxr-20250107.xsd EX-101.SCH 3027
7 XBRL LABEL FILE ctxr-20250107_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE ctxr-20250107_pre.xml EX-101.PRE 22367
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0227130-8k_citius_htm.xml XML 3677
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38174 | Film No.: 25518561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)